Launch of the ProVac-EPIC Supplement to Vaccine

12 May 2015

“Expanding the evidence base to inform vaccine introduction: program costing and cost-effectiveness analyses”

provac-vaccine-launch.png

The Pan American Health Organization/World Health Organization coordinated the new series of studies recently published on Vaccine Supplement titled "Expanding the Evidence Base to Inform Vaccine Introduction: Program Costing and Cost-Effectiveness Analyses". 

All articles can be accessed here.

The supplement includes 31 original research articles, nine of which are from the Americas (from Argentina, Belize, Brazil, Honduras, Paraguay and Peru), and four perspective articles by global experts in health economics and decision science. The original research includes 14 country-led cost-effectiveness analyses and nine country costing and financial flows analyses that incorporate new data collected from over 300 primary health care facilities in six countries. The four perspective articles address subjects including the potential role of cost-effectiveness analysis in vaccine price negotiations, the continued need for models and methodological approaches that can be adapted for use in low resource policy settings, and the challenges of supporting country-level decision making in the context of donors' priority setting.

Related News & Events

  • SAGE

    new Interim Recommendations on Vaccination against Ebola Virus Disease from SAGE

    13.05.2019

    Over the last four weeks, the Ebola outbreak in the Eastern Provinces of the Democratic Republic of Congo (DRC) has deteriorated with a large increase in the number of cases1. A major factor in this rise is an increase in critical security incidents that have dramatically affected the ability to identify, follow up and vaccinate contacts successfully. This context challenges the implementation of ring vaccination based on the identification of contacts and contacts of contacts, as recommended by SAGE in April 2017 and confirmed by SAGE during its April 2019 meeting. Further, a potential vaccine shortage may manifest in case the outbreak expands further and/or is prolonged.

    Read more
  • Network

    Are you the next GNN chair?

    26.03.2019

    The secretariat of the Global NITAG Network is proud to announce an open call for nomination for the new chair for a 2 year mandate.  The vacant will be generated when Pr Anthony Harnden ends his term in June 2019.

    Read more
  • Belgium
    SAGE

    New advisory report for the vaccination against Tick-Borne Encephalitis

    21.03.2019

    The Superior Health Council (SHC) received 2 requests for an advisory report by letter, on May 12 2017 from the Risk Management Group (FPS Health, Food Chain Safety and Environment) and on November 14 2018 from the federal Minister of Health. Both requests are treated in this advisory report.
     

    Read more